22 results
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Aspergillosis - IDSA ... Guidelines - ... #pharmacology # ... dosing #medications ... #IDSA #Guidelines
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
DAAs #Antivirals #table ... #treatment #hcv ... #medications #infectiousdisease ... HepatitisC #Management #Pharmacology
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Guidelines # ... Therapy #regimens #medications ... #pharmacology # ... IDSA #Guidelines ... #Treatment
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... or been newly diagnosed ... following initial diagnosis ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... Potential Treatment ... Agents for Treatment ... infection Episode #Pharmacology
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
with ‘treatment ... summarised in Tables ... EBM #Management #Pharmacology ... Personality #Disorder #Medications ... Effectiveness #Table
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... for Preventing ... #Encephalitis #IDSA ... #Prevention #Treatment ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... mucoadhesive buccal tablet ... chew, or crush tablet ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Dosing: 250 mcg tablet ... 2019 COPD GOLD guidelines ... recommendations for the treatment ... the use of this medication ... #Pharmacology #
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Tx Management (IDSA ... /severe CDI IDSA ... 2021 CDI Treatment ... Guideline: https ... #infectiousdiseases